Eavesdropper: Tested development
In October 2020, the FDA authorised Aptima SARS-CoV-2 assay to test individuals without symptoms given the sensitivity and accuracy. While vaccine-related developments have certainly been a hallmark of rapid technology development in the last year, developments on the testing front have mostly gone unnoticed. Given the experience with earlier SARS infections, countries could scale up … Read more